FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders FSD Pharma Inc., a biopharmaceutical company dedicated to innovative solutions for neurodegenerative, inflammatory, and metabolic disorders, has released the outcomes of its annual general and special meeting of shareholders held on June 29, 2023. During the meeting, there were 148 shareholders present or rep..